Statistics

Total Visits

Views
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program107

Select a period of time:

Number of views in the range

Views
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program27

Views

Views
October 20252
November 20252
December 20251
January 202615
February 20261
March 20266
April 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States15
Spain3
Argentina2
Australia1
China1
Ecuador1
Ethiopia1
United Kingdom1
Mexico1
Paraguay1
 

Top cities views

Views
San Jose10
A Coruña2
Addis Ababa1
Alcorta1
Bell Ville1
Machala1
Madrid1
Salto del Guairá1
Zapopan1